DK0973774T3 - 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivater - Google Patents
1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivaterInfo
- Publication number
- DK0973774T3 DK0973774T3 DK98913595T DK98913595T DK0973774T3 DK 0973774 T3 DK0973774 T3 DK 0973774T3 DK 98913595 T DK98913595 T DK 98913595T DK 98913595 T DK98913595 T DK 98913595T DK 0973774 T3 DK0973774 T3 DK 0973774T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyrazolo
- dihydro
- pyrimidinone derivatives
- diseases
- medicaments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Vascular Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19709877A DE19709877A1 (de) | 1997-03-11 | 1997-03-11 | 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate |
PCT/EP1998/001086 WO1998040384A1 (fr) | 1997-03-11 | 1998-02-26 | Derives de 1,5-dihydro-pyrazolo[3,4-d]-pyrimidinone |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0973774T3 true DK0973774T3 (da) | 2003-05-05 |
Family
ID=7822900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98913595T DK0973774T3 (da) | 1997-03-11 | 1998-02-26 | 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivater |
Country Status (18)
Country | Link |
---|---|
US (1) | US6174884B1 (fr) |
EP (1) | EP0973774B1 (fr) |
JP (1) | JP2001514638A (fr) |
KR (1) | KR20000076124A (fr) |
CN (1) | CN1151155C (fr) |
AT (1) | ATE231509T1 (fr) |
AU (1) | AU727615B2 (fr) |
BR (1) | BR9807995A (fr) |
CA (1) | CA2283211A1 (fr) |
DE (2) | DE19709877A1 (fr) |
DK (1) | DK0973774T3 (fr) |
ES (1) | ES2191294T3 (fr) |
HK (1) | HK1028035A1 (fr) |
HU (1) | HUP0001805A3 (fr) |
IL (1) | IL131450A0 (fr) |
NZ (1) | NZ337724A (fr) |
RU (1) | RU2219180C2 (fr) |
WO (1) | WO1998040384A1 (fr) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9823103D0 (en) * | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
JP2004505054A (ja) | 2000-08-01 | 2004-02-19 | バイエル アクチェンゲゼルシャフト | 知覚を改善する医薬品としての選択的pde2インヒビター |
CA2431077A1 (fr) * | 2000-12-19 | 2002-06-27 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Formulation pharmaceutique contenant des pyrazolo[4,3-d]pyrimidines et des antithrombotiques, des antagonistes de calcium, des prostaglandines ou des derives de prostaglandine |
DE10064105A1 (de) | 2000-12-21 | 2002-06-27 | Bayer Ag | Neue Substituierte Imidazotriazinone |
HUP0303005A3 (en) * | 2001-02-02 | 2005-05-30 | Merck Patent Gmbh | Pharmaceutical compositions comprising pyrazolo[4,3-d]pyrimidines or thienopyrimidines and endothelin receptor antagonists |
KR100393160B1 (ko) * | 2001-06-14 | 2003-07-31 | 한국과학기술연구원 | 신규한 피라졸로피리미딘티온 유도체, 그의 제법 및발기부전 치료제로서의 용도 |
US6479493B1 (en) | 2001-08-23 | 2002-11-12 | Cell Pathways, Inc. | Methods for treatment of type I diabetes |
US7307097B2 (en) * | 2001-09-27 | 2007-12-11 | Smithkline Beechman Corporation | Chemical compounds |
FR2842809A1 (fr) * | 2002-07-26 | 2004-01-30 | Greenpharma Sas | NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION |
DE10238724A1 (de) * | 2002-08-23 | 2004-03-04 | Bayer Ag | Alkyl-substituierte Pyrazolpyrimidine |
DE10238722A1 (de) | 2002-08-23 | 2004-03-11 | Bayer Ag | Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse |
DE10238723A1 (de) * | 2002-08-23 | 2004-03-11 | Bayer Ag | Phenyl-substituierte Pyrazolyprimidine |
CN100397023C (zh) * | 2003-01-04 | 2008-06-25 | 胡云北 | 黄磷废渣载热量及反应尾气发热量的回收与综合利用方法 |
US20060106037A1 (en) * | 2003-03-04 | 2006-05-18 | Thomas Bar | Purin-6-one-derivatives |
DE102004004142A1 (de) | 2003-05-09 | 2004-11-25 | Bayer Healthcare Ag | 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine |
US8044060B2 (en) | 2003-05-09 | 2011-10-25 | Boehringer Ingelheim International Gmbh | 6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory |
DE10320785A1 (de) | 2003-05-09 | 2004-11-25 | Bayer Healthcare Ag | 6-Arylmethyl-substituierte Pyrazolopyrimidine |
DE10328479A1 (de) | 2003-06-25 | 2005-01-13 | Bayer Ag | 6-Arylamino-5-cyano-4-pyrimidinone |
US20060229242A1 (en) * | 2003-08-28 | 2006-10-12 | Altana Phazma Ag | Composition comprising a pulmonary surfactant and a pde2 inhibitor |
DE102004001873A1 (de) | 2004-01-14 | 2005-09-29 | Bayer Healthcare Ag | Cyanopyrimidinone |
MXPA06009462A (es) * | 2004-02-27 | 2007-03-15 | Hoffmann La Roche | Derivados pirazolo heteroaril fusionados. |
CN101397299B (zh) * | 2007-09-29 | 2011-11-16 | 温州大学 | 一种吡唑[3,4-d]嘧啶酮的合成方法 |
JP5498392B2 (ja) | 2007-11-30 | 2014-05-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 1,5−ジヒドロ−ピラゾロ[3,4−d]ピリミジン−4−オン誘導体及びcns障害の治療のためのpde9aモジュレーターとしてのそれらの使用 |
UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
NZ590788A (en) | 2008-09-08 | 2012-11-30 | Boehringer Ingelheim Int | Pyrazolopyrimidines and their use for the treatment of cns disorders |
WO2010114896A1 (fr) | 2009-03-31 | 2010-10-07 | Arqule, Inc. | Composés indolo-pyridinone substitués |
MX2011010184A (es) | 2009-03-31 | 2011-10-28 | Boehringer Ingelheim Int | Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4 -ona y su uso como moduladores de pde9a. |
AR077859A1 (es) * | 2009-08-12 | 2011-09-28 | Boehringer Ingelheim Int | Compuestos para el tratamiento de trastornos del snc |
CN105541849B (zh) | 2010-08-12 | 2018-03-23 | 勃林格殷格翰国际有限公司 | 6‑环烷基‑1,5‑二氢‑吡唑并[3,4‑d]嘧啶‑4‑酮衍生物及其作为PDE9A抑制剂的用途 |
US20130040971A1 (en) | 2011-02-14 | 2013-02-14 | Boehringer Ingelheim International Gmbh | 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders |
US8809345B2 (en) | 2011-02-15 | 2014-08-19 | Boehringer Ingelheim International Gmbh | 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders |
ES2602794T3 (es) | 2011-03-31 | 2017-02-22 | Pfizer Inc | Piridinonas bicíclicas novedosas |
WO2012172449A1 (fr) | 2011-06-13 | 2012-12-20 | Pfizer Inc. | Lactames convenant comme inhibiteurs des bêta-sécrétases |
JP6043355B2 (ja) | 2011-08-31 | 2016-12-14 | ファイザー・インク | ヘキサヒドロピラノ[3,4−d][1,3]チアジン−2−アミン化合物 |
JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
UA110688C2 (uk) | 2012-09-21 | 2016-01-25 | Пфайзер Інк. | Біциклічні піридинони |
BR112015019276A2 (pt) | 2013-02-19 | 2017-07-18 | Pfizer | compostos de azabenzimidazol como inibidores de isoenzimas de pde4 para o tratamento de distúrbios do snc e outros distúrbios |
ES2742078T3 (es) | 2013-10-04 | 2020-02-13 | Pfizer | Piridonas bicíclicas novedosas como moduladores de gamma-secretasa |
MX369074B (es) | 2014-04-01 | 2019-10-28 | Pfizer | Cromeno y 1,1a,2,7b-tetrahidrociclopropa[c]cromeno piridopirazinadionas como moduladores de la gamma secretasa. |
JP6713982B2 (ja) | 2014-07-24 | 2020-06-24 | ファイザー・インク | ピラゾロピリミジン化合物 |
ES2733502T3 (es) | 2014-08-06 | 2019-11-29 | Pfizer | Compuestos de imidazopiridazina |
PE20171318A1 (es) | 2015-02-03 | 2017-09-07 | Pfizer | Ciclopropabenzofuranil-piridopirazindionas novedosas |
JO3627B1 (ar) | 2015-04-30 | 2020-08-27 | H Lundbeck As | إيميدازو بيرازينونات على هيئة مثبطات pde1 |
EP3291817B1 (fr) * | 2015-05-05 | 2019-10-02 | Merck Sharp & Dohme Corp. | Composés d'hétéroaryl-pyrimidinone en tant qu'inhibiteurs de pde2 |
EP3766885B1 (fr) | 2015-06-17 | 2022-05-25 | Pfizer Inc. | Composés tricycliques comme inhibiteurs de la phosphodiesterase |
CN108699080B (zh) | 2016-02-23 | 2021-05-14 | 辉瑞公司 | 6,7-二氢-5H-吡唑并[5,1-b][1,3]噁嗪-2-甲酰胺化合物 |
TWI729109B (zh) | 2016-04-12 | 2021-06-01 | 丹麥商H 朗德貝克公司 | 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮 |
DK3478679T3 (da) | 2016-07-01 | 2021-06-21 | Pfizer | 5,7-dihydro-pyrrolo-pyridin-derivater til behandling af neurologiske og neurodegenerative sygdomme |
EP3529250B1 (fr) * | 2016-10-18 | 2023-12-06 | H. Lundbeck A/S | Imidazopyrazinones, pyrazolopyrimidinones et pyrazolopyridinones en tant qu'inhibiteurs de pde1 |
CA3041595A1 (fr) | 2016-10-28 | 2018-05-03 | H. Lundbeck A/S | Traitements combines comprenant l'administration d'imidazopyrazinones |
MA46611B1 (fr) | 2016-10-28 | 2020-08-31 | H Lundbeck As | Traitements combinés comprenant des imidazopyrazinones pour le traitement de troubles psychiatriques et/ou cognitifs |
EP3562828A1 (fr) | 2016-12-28 | 2019-11-06 | Dart NeuroScience LLC | Composés pyrazolopyrimidinone substitués en tant qu'inhibiteurs de pde2 |
AU2018281131B2 (en) | 2017-06-08 | 2022-01-20 | Merck Sharp & Dohme Corp. | Pyrazolopyrimidine PDE9 inhibitors |
FI3642202T3 (fi) | 2017-06-22 | 2023-03-01 | Dihydro-pyrrolo-pyridiinijohdannaisia | |
MX2020005447A (es) | 2017-11-27 | 2020-12-03 | Dart Neuroscience Llc | Compuestos de furanopirimidina sustituida como inhibidores de pde1. |
DK3768669T3 (da) | 2018-03-23 | 2023-04-24 | Pfizer | Piperazinazaspiroderivater |
USD1029414S1 (en) * | 2021-01-19 | 2024-05-28 | Averia Electronics, Inc. | Wearable light emitting module with a removable band |
USD1021287S1 (en) * | 2021-01-19 | 2024-04-02 | Averia Electronics, Inc. | Wearable light emitting module with a removable band |
WO2024118524A1 (fr) | 2022-11-28 | 2024-06-06 | Cerevel Therapeutics, Llc | Composés d'azaindole et leur utilisation en tant qu'inhibiteurs de phosphodiestérase |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3211732A (en) | 1965-10-12 | Pyrazolob:x-d]pyrlil/hdines | ||
DE1153023B (de) | 1960-05-11 | 1963-08-22 | Ciba Geigy | Verfahren zur Herstellung von 4-Hydroxy-pyrazolo[3,4-d] pyrimidinen |
CH398626A (de) * | 1960-05-11 | 1966-03-15 | Ciba Geigy | Verfahren zur Herstellung neuer Pyrazolopyrimidine |
CH633297A5 (de) | 1977-09-16 | 1982-11-30 | Sandoz Ag | Verfahren zur herstellung von fluorenphosphoniten. |
GB9121028D0 (en) | 1991-10-03 | 1991-11-13 | Pfizer Ltd | Therapeutic agents |
US5294612A (en) * | 1992-03-30 | 1994-03-15 | Sterling Winthrop Inc. | 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof |
WO1996028448A1 (fr) | 1995-03-10 | 1996-09-19 | Sanofi Winthrop, Inc. | 6-aryl pyrazolo[3,4-d]pyrimidin-4-ones, compositions et procedes d'utilisation de ces composes |
US5656629A (en) * | 1995-03-10 | 1997-08-12 | Sanofi Winthrop, Inc. | 6-substituted pyrazolo (3,4-d)pyrimidin-4-ones and compositions and methods of use thereof |
-
1997
- 1997-03-11 DE DE19709877A patent/DE19709877A1/de not_active Withdrawn
-
1998
- 1998-02-26 WO PCT/EP1998/001086 patent/WO1998040384A1/fr not_active Application Discontinuation
- 1998-02-26 DK DK98913595T patent/DK0973774T3/da active
- 1998-02-26 RU RU99121518/04A patent/RU2219180C2/ru not_active IP Right Cessation
- 1998-02-26 KR KR1019997008213A patent/KR20000076124A/ko not_active Application Discontinuation
- 1998-02-26 ES ES98913595T patent/ES2191294T3/es not_active Expired - Lifetime
- 1998-02-26 AU AU68240/98A patent/AU727615B2/en not_active Ceased
- 1998-02-26 AT AT98913595T patent/ATE231509T1/de not_active IP Right Cessation
- 1998-02-26 HU HU0001805A patent/HUP0001805A3/hu unknown
- 1998-02-26 JP JP53913598A patent/JP2001514638A/ja not_active Withdrawn
- 1998-02-26 IL IL13145098A patent/IL131450A0/xx not_active IP Right Cessation
- 1998-02-26 CN CNB988049872A patent/CN1151155C/zh not_active Expired - Fee Related
- 1998-02-26 NZ NZ337724A patent/NZ337724A/xx unknown
- 1998-02-26 EP EP98913595A patent/EP0973774B1/fr not_active Expired - Lifetime
- 1998-02-26 CA CA002283211A patent/CA2283211A1/fr not_active Abandoned
- 1998-02-26 DE DE59807011T patent/DE59807011D1/de not_active Expired - Fee Related
- 1998-02-26 BR BR9807995-6A patent/BR9807995A/pt not_active IP Right Cessation
- 1998-02-26 US US09/367,538 patent/US6174884B1/en not_active Expired - Fee Related
-
2000
- 2000-11-17 HK HK00107378A patent/HK1028035A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2001514638A (ja) | 2001-09-11 |
EP0973774B1 (fr) | 2003-01-22 |
CA2283211A1 (fr) | 1998-09-17 |
DE59807011D1 (de) | 2003-02-27 |
CN1255133A (zh) | 2000-05-31 |
US6174884B1 (en) | 2001-01-16 |
ATE231509T1 (de) | 2003-02-15 |
IL131450A0 (en) | 2001-01-28 |
HUP0001805A2 (hu) | 2000-11-28 |
HK1028035A1 (en) | 2001-02-02 |
ES2191294T3 (es) | 2003-09-01 |
DE19709877A1 (de) | 1998-09-17 |
RU2219180C2 (ru) | 2003-12-20 |
NZ337724A (en) | 2000-08-25 |
AU6824098A (en) | 1998-09-29 |
HUP0001805A3 (en) | 2002-09-30 |
BR9807995A (pt) | 2000-03-08 |
KR20000076124A (ko) | 2000-12-26 |
WO1998040384A1 (fr) | 1998-09-17 |
CN1151155C (zh) | 2004-05-26 |
EP0973774A1 (fr) | 2000-01-26 |
AU727615B2 (en) | 2000-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59807011D1 (de) | 1,5-dihydro-pyrazolo 3,4-d]-pyrimidinon-derivate | |
TR199800012T1 (xx) | Piroloprimidinler ve preparasyon i�in tatbikler. | |
ZA975866B (en) | Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases. | |
TR199902538T2 (xx) | Yeni bile�imler. | |
DE69011059D1 (de) | Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
AU6194694A (en) | Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
ATE5880T1 (de) | Imidazol-5-essigsaeurederivate, ihre herstellung und verwendung. | |
DE69529173D1 (de) | Heterozyklische bizykeln zur behandlung von impotenz | |
DE10299001I1 (de) | Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel. | |
NO903088D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater. | |
MX9605371A (es) | Derivados de purin-6-ona y procedimiento para su produccion. | |
NZ516349A (en) | Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease | |
ID29790A (id) | PENGGUNAAN IMIDAZO(1,5-a)-PIRIDO(3,2-e)-PIRAZINON SEBAGAI OBAT | |
NO164542C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)-pyrimidinderivater. | |
ES2124861T3 (es) | Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa. | |
ZA925892B (en) | Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases. | |
DE3865073D1 (de) | Imidazopyridinderivate, ihre herstellung und therapeutische verwendung. | |
DK0391185T3 (da) | 1,8-Naphthyridiner | |
NO301826B1 (no) | Heterotricyklisk substituerte fenylcykloheksankarboksylsyrederivater, legemidler inneholdende dem og deres anvendelse for fremstilling av legemidler | |
DE58907399D1 (de) | Cyclopropyl-Substituierte Azolylmethylcarbinole, Verfarhren zu ihrer Herstellung und ihre Verwendung als Arzneimittel. | |
DK0538690T3 (da) | Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler | |
AU5903690A (en) | Use in therapy of 10-amino-5,6-dihydro-11h-dibenzo(b,e) azepine-6, 11-dione and derivatives as drugs for use in the treatment of urinary incontinence | |
DE3875807D1 (de) | 3-acylaminomethyl-5,6,7,8-tetrahydroimidazo(1,2-a)pyridinderivate, ihre herstellung und therapeutische verwendung. | |
NO904470D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater. | |
WO1999024052A3 (fr) | Utilisation de la proteine h en tant qu'agent cytostatique |